Tryptase Test · Blood

Your blood contains a constant trickle of a protein that reflects the size and activity of a specific immune cell population called mast cells. When that number climbs above the normal range, it signals one of three things: a recent severe allergic reaction, a genetic trait that raises your baseline risk for anaphylaxis, or, less commonly, a rare disease where mast cells multiply abnormally.

If you have had unexplained anaphylaxis, repeated severe reactions to bee stings, episodes that felt like allergic reactions without a clear trigger, or persistent symptoms like flushing, hives, and low blood pressure, this number tells you whether your immune machinery is loaded in a way that makes severe reactions more likely. It is one of the few blood tests that can explain why some people react harder than others.

What This Enzyme Reflects

Tryptase is an enzyme stored inside mast cells, which are immune cells that sit in your skin, airways, gut, and other tissues exposed to the outside world. Mast cells are the engines of allergic reactions. When they are triggered, they dump their contents, including tryptase and histamine, into the surrounding tissue and bloodstream.

There are two things your blood level reflects, and it helps to keep them separate. Your baseline tryptase, measured when you feel fine, reflects the total number of mast cells in your body. A higher baseline means you carry more mast cells than the average person, either because of a genetic trait or, rarely, because of a mast cell disease. Acute tryptase, measured shortly after a reaction, reflects how hard those cells just fired.

Why Your Baseline Matters

An elevated baseline is not just a number. It is a standing risk factor for severe allergic reactions. People with higher baseline tryptase are more likely to have life-threatening responses to insect stings, drugs, radiocontrast dyes, and food allergens. If you have ever had a reaction that seemed out of proportion to the trigger, your baseline may be part of the explanation.

The most common reason for an elevated baseline, by a wide margin, is a genetic trait called hereditary alpha-tryptasemia, where a person inherits extra copies of the tryptase gene. About 4 to 6 percent of the general population carries this trait. In one large regional health system study of people with elevated baseline levels, 64 percent of cases were explained by this trait, 21 percent by bone marrow disorders, and 12 percent by chronic kidney disease.

Anaphylaxis Risk and Severity

During anaphylaxis, mast cells dump their contents into the blood within minutes. Tryptase peaks 30 to 60 minutes after symptoms start and usually returns to baseline within 2 to 4 hours. The level climbs with the severity of the reaction, and people with hypotension during a reaction tend to have the highest acute values.

The validated diagnostic rule for confirming that a reaction was driven by mast cell activation is this: your acute level must be greater than (1.2 times your baseline) plus 2 ng/mL. A single value below the lab's upper limit does not rule out anaphylaxis, because the meaningful signal is the change from your own baseline, not the absolute number.

Mast Cell Diseases

Systemic mastocytosis is a rare bone marrow disorder where mast cells accumulate in excess. A baseline tryptase above 20 ng/mL is one of four minor diagnostic criteria used by the World Health Organization, but the number alone cannot diagnose the disease. Bone marrow evaluation and genetic testing for a specific mutation called KIT D816V are needed to confirm it.

Mast cell activation syndrome is a separate condition where mast cells release their contents inappropriately without forming tumors. Tryptase may rise during symptomatic episodes but baseline levels are often normal, so this test alone cannot rule it in or out.

Kidney Disease Progression

One prospective study of 446 adults with advanced chronic kidney disease found that among those on standard blood pressure medications (ACE inhibitors or ARBs), people with the highest tryptase levels were about 6 times more likely to progress to end-stage kidney disease than those in the lowest third (hazard ratio 6.19). The middle third also had roughly 6 times higher risk (hazard ratio 5.78). The association held after adjusting for age, sex, kidney filtration rate, and protein in the urine. In the same study, tryptase was not linked to death, only to kidney failure progression.

What this means for you: if you already have chronic kidney disease, a higher tryptase may flag a faster trajectory toward dialysis. It does not replace standard kidney markers, but it adds information that standard markers miss.

Heart Disease Signals

Several smaller studies have connected higher tryptase to cardiovascular findings, though these are snapshots rather than long-term follow-up studies. In a Chinese cohort of 270 people undergoing cardiac catheterization, average tryptase was about 30 percent higher in people with significant coronary artery disease than in those without, and roughly doubled in people with acute heart attack compared to people without coronary disease. The association held after accounting for traditional risk factors. A separate study of 228 people linked higher tryptase to thicker neck artery walls, an early sign of atherosclerosis.

These findings are consistent but preliminary. No large population studies have tracked baseline tryptase and then watched for heart attacks or strokes over years, so the cardiovascular signal should be treated as suggestive rather than actionable.

Reference Ranges

Age is the biggest source of variation in your baseline, so interpret your number in light of how old you are. Median levels rise from about 4 ng/mL in young adults to about 6.6 ng/mL in people over 80.

These tiers are drawn from published research and expert consensus from the European Competence Network on Mastocytosis and American Initiative in Mast Cell Diseases. Your lab may use slightly different assays and cutpoints. Compare your results within the same lab over time for the most meaningful trend. Many commercial labs still flag anything above 11.4 ng/mL, but this threshold is based on older data that did not separate out the hereditary trait.

Tracking Your Trend

Tryptase is unusually stable from day to day. In healthy adults, the within-person variation is only about 3.7 percent, with no meaningful change across the day and no effect from fasting. Among people with already-elevated baselines, though, variation is larger: in one study, about 41 percent of people with elevated tryptase showed swings big enough to meet the diagnostic threshold for mast cell activation even when they had no symptoms.

Get a baseline measurement when you feel well, at least 24 hours after any allergic reaction or symptoms. If your level is elevated or borderline, retest in 3 to 6 months to confirm the trend before pursuing further workup. If you have had an unexplained severe reaction, you need two values: one drawn within 30 minutes to 2 hours of the reaction, and a second drawn at least a day after you have fully recovered. The comparison between those two numbers is what tells you whether mast cells were the cause.

When Results Can Be Misleading

• Timing around a reaction: drawing blood more than 4 to 6 hours after symptoms start usually misses the spike, since tryptase returns to baseline within 2 to 4 hours. Drawing blood during or immediately after a reaction and calling that your baseline is also a common error.
• Hereditary alpha-tryptasemia: carrying extra copies of the tryptase gene raises your baseline for life. Without genetic testing, a level in the 10 to 20 ng/mL range can be mistaken for a warning of mast cell disease when it is simply your inherited baseline.
• Chronic kidney disease: reduced kidney function slows clearance of tryptase from the blood, raising levels without any change in mast cell activity. This accounts for roughly 12 percent of elevated baseline cases in general medical populations.
• Heavy alcohol use: chronic heavy drinking has been associated with lower tryptase concentrations, which could mask an underlying elevation.